Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21
Recall Number: D-0801-2021
Firm: Meitheal Pharmaceuticals Inc
Classification: Class III
Status: Terminated
Report Date: 20210922
Initiation Date: 20210903
Termination Date: 20240512
Reason for Recall
Failed Impurities/Degradation Specifications
Product Description
Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21